[1] Patel NS, Paghdal KV, Cohen GF. Advanced treatment modalities for vitiligo. Dermatol Surg. 2012, 38(3):381-391.
[2] Cimadamore F, Shah M, Amador-Arjona A, et al.SOX2 Modulates Levels of MITF in Human Embryonic Stem Cell - Derived Neural Crest, Normal Human Melanocytes, and Melanoma Lines In Vitro. Pigment Cell Melanoma Res. 2012 May 9. [Epub ahead of print]
[3] Yang R, Jiang M, Kumar SM, et al. Generation of melanocytes from induced pluripotent stem cells. J Invest Dermatol. 2011, 131(12):2458-2466.
[4] Tirino V, Paino F, De Rosa A, et al. Identification, isolation, characterization, and banking of human dental pulp stem cells. Methods Mol Biol. 2012, 879:443-463.
[5] Paino F, Ricci G, De Rosa A, et al. Ecto-mesenchymal stem cells from dental pulp are committed to differentiate into active melanocytes. Eur Cell Mater. 2010, 20:295-305.
[6] Yew TL, Chang MC, Hsu YT, et al. Efficient expansion of mesenchymal stem cells from mouse bone marrow under hypoxic conditions. J Tissue Eng Regen Med. 2012 May 24. [Epub ahead of print]
[7] 刘卫东, 任彩萍, 姚开泰. 人胚胎干细胞的体外定向分化. 生命科学, 2007, 19(5):518-525.
[8] Tirino V, Paino F, d'Aquino R, et al. Methods for the identification, characterization and banking of human DPSCs: current strategies and perspectives. Stem Cell Rev. 2011; 7(3): 608-615.
[9] Alikhan A, Felsten LM, Daly M, et al. Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol. 2011, 65(3):473-91.
[10] Patel NS, Paghdal KV, Cohen GF. Advanced treatment modalities for vitiligo. Dermatol Surg. 2012, 38(3):381-391.
[11] Saitoh A, Kawanabe T, Weidong H,et al. Selective upregulation of fibroblast Fas ligand expression, and prolongation of Fas/Fas ligand-mediated skin allograft survival, by retinoic acid: the skin as a retinoide-inducible immune privilege site. J Invest Dermatol. 2000, 115(2): 154-161.
[12] 董达科, 项蕾红. 毛囊干细胞向黑素细胞系定向分化调控机制的研究进展. 国际皮肤性病学杂志. 2011, 37(4): 255-257.
[13] Li Y, Chen J, Wang L,et al. Intracerebral transplantation of bone marrow stromal cells in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Neurosci Lett. 2001, 316(2):67-70.
[14] Malgieri A, Kantzari E, Patrizi MP, et al. Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art. Int J Clin Exp Med. 2010, 3(4):248-269.
[15] Ke-Xin S, Qun Q, Da-Qing L, et al. Application of melanocytes and bone marrow mesenchymal stem cells in tissue engineered skin construction. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2011, 33(4):402-407.
[16] Kagami H, Agata H, Tojo A, et al. Bone marrow stromal cells (bone marrow-derived multipotent mesenchymal stromal cells) for bone tissue engineering: basic science to clinical translation. Int J Biochem Cell Biol. 2011, 43(3):286-289.
[17] Halaban R. Signal transduction in normal and malignant melanocytes. Pigment Cell Res. 1994, 7(2):89-95.
[18] Murisier F, Beermann F. Genetics of pigment cells: lessons from the tyrosinase gene family. Histol Histopathol. 2006, 21(5):567-578.
[19] Aksan I, Goding CR. Targeting the microphthalmia basic helix-loop-helix-leucine zipper transcription factor to a subset of E-box elements in vitro and in vivo. Mol Cell Biol. 1998,18(12):6930-6938.
[20] Levy C, Khaled M, Fisher DE. MITF: master regulator of melanocyte development and melanoma oncogene. Trends Mol Med. 2006,12: 406-414.
|